CONCLUSIONS: The results of this population-based cohort study indicate that Medikinet^(®) MR and Concerta^(®) have comparable real-world safety profiles.
CONCLUSIONS: The results of this population-based cohort study indicate that Medikinet^(®) MR and Concerta^(®) have comparable real-world safety profiles.